David Altshuler - Feb 10, 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 10, 2023
Transactions value $
-$4,239,380
Form type
4
Date filed
2/14/2023, 03:49 PM
Previous filing
Feb 8, 2023
Next filing
Feb 16, 2023

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
F2 Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $296.44 (range $295.84 to $296.57).
F4 Open market sales reported on this line occurred at a weighted average price of $298.47 (range $297.85 to $298.82).
F5 Open market sales reported on this line occurred at a weighted average price of $299.36 (range $298.86 to $299.83).
F6 Open market sales reported on this line occurred at a weighted average price of $300.23 (range $299.96 to $300.63).